Temple University/Fox Chase Cancer Center is a Philadelphia-based academic cancer center and institutional healthcare investor with strategic relevance in oncology, life sciences, biotechnology and healthtech. Its private-market investing includes later-stage venture participation in a United States AI and healthtech company, making it most relevant for founders seeking strategic academic medical-center capital rather than a conventional venture fund.